Appointments

Regulatory affairs, QA personnel hired

Published in Vaccine Weekly, March 6th, 2002

VaxGen, Inc., (VXGN) announced the hiring of two professionals with distinguished track records to help the company submit its AIDS vaccine for regulatory approval if the vaccine, AIDSVAX, proves effective approximately 12 months from now.

VaxGen named Carmen M. Betancourt vice president of regulatory affairs and quality assurance. Betancourt has 24 years of experience in biologics and the biotechnology industry, 14 of which have been spent in regulatory affairs. She served most recently as vice president, Regulatory Affairs, at Titan Pharmaceuticals, where she managed multiple product development programs supporting the clinical investigation of pharmaceutical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry